RT Journal Article
SR Electronic
T1 Using the new HPV vaccines in clinical practice
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 929
OP 935
VO 73
IS 10
A1 Lea E. Widdice
A1 Jessica A. Kahn
YR 2006
UL http://www.ccjm.org/content/73/10/929.abstract
AB Gardasil, a vaccine against human papillomavirus (HPV), recently became available in the United States for use in girls and women 9 to 26 years of age. A second HPV vaccine, Cervarix, is under development. These vaccines constitute the most significant development in cervical cancer prevention in the last 60 years, having the potential to reduce the incidence of cervical cancer by up to 70%.